Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Novation Holdings
Its shares trade under the ticker NOHO. It has been listed since 20 December 2010. In the fiscal year to 31 August 2015, it reported revenue of $9,373 and net income of $94,715. At that date it held total assets of $65,000 and shareholders' equity of −$653,551.
Novation Holdings, Inc. engages in manufacturing, developing and marketing of medical devices. The company is headquartered in Calgary, Alberta. The company went IPO on 2010-12-20. The firm is also focusing other related acquisitions in the Internet service provider (ISP) field, as well as in other market segments. The firm through its subsidiaries, Burgoyne Internet Services, Inc., a regional ISP and Novation Consulting Services, Inc., an administrative service company, provides management, administrative, financial and other support services.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Biotechnology
- Listed since
- 20 Dec 2010
- Employees
- 2
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Dragon Life Science Holdings Group Inc has several strengths which contribute to its competitive advantage:
- Dragon Life Science holds a robust portfolio of intellectual property rights, including patents, trademarks, and trade secrets. This provides the company with a strong foundation for innovation and market differentiation.
- The company has well-established distribution channels, enabling it to reach a wide customer base. These channels allow Dragon Life Science to efficiently distribute its products and services, ensuring a competitive edge in the market.
- Dragon Life Science is led by a highly experienced and knowledgeable management team. Their expertise in the life sciences industry enables effective decision-making, strategic planning, and efficient execution of business strategies.
Weaknesses
- Despite its strengths, Dragon Life Science Holdings Group Inc also faces certain weaknesses:
- The company currently has limited financial resources, which may restrict its ability to invest in research and development, expand its operations, or pursue new market opportunities.
- Dragon Life Science relies heavily on key strategic partners for various aspects of its business, such as manufacturing, distribution, and licensing. This dependence introduces risks if these partners face challenges or terminate their collaborations.
- As a life science company, Dragon Life Science is subject to stringent regulatory requirements, which pose challenges and potential delays in terms of product development, testing, and obtaining necessary approvals.
Opportunities
- Dragon Life Science can capitalize on the following opportunities to further grow its business:
- The increasing focus on healthcare, advancements in genetics and personalized medicine, and a growing aging population present opportunities for Dragon Life Science to develop innovative solutions to address these market needs.
- The company can explore expansion into emerging markets, where demand for life science products and services is rapidly increasing. By entering these markets, Dragon Life Science can tap into new customer segments and drive revenue growth.
- Forming strategic collaborations and partnerships with other industry players, academic institutions, and research organizations can enhance Dragon Life Science's research capabilities, market reach, and access to expertise, potentially leading to breakthrough innovations.
Threats
- Dragon Life Science should be mindful of the following threats that could impact its business:
- The life sciences industry is highly competitive, with numerous established companies and emerging startups vying for market share. Dragon Life Science must continuously innovate and differentiate itself to remain competitive and capture market opportunities.
- Changes in regulations, compliance requirements, and government policies can significantly impact the operations and market opportunities for Dragon Life Science. Staying up-to-date with evolving regulations and adapting quickly is crucial for the company's success.
- The rapid pace of technological advancements in the life sciences sector poses both opportunities and threats for Dragon Life Science. While it can leverage emerging technologies for innovation, there is also the risk of disruption by competitors or obsolescence of existing products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.